2019
DOI: 10.1007/s11239-019-01852-7
|View full text |Cite
|
Sign up to set email alerts
|

Variation in platelet expression of FcγRIIa after myocardial infarction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 29 publications
0
6
0
Order By: Relevance
“…[61] FCGR2A encodes one member of a family of immunoglobulin fold change receptor genes found on the surface of many immune response cells. [62] Proteomics analysis showed that FCGR2A mediates angiogenesis in a rodent model of vascular disease. [63] The protein encoded by IL10RA is a receptor for interleukin 10.…”
Section: Discussionmentioning
confidence: 99%
“…[61] FCGR2A encodes one member of a family of immunoglobulin fold change receptor genes found on the surface of many immune response cells. [62] Proteomics analysis showed that FCGR2A mediates angiogenesis in a rodent model of vascular disease. [63] The protein encoded by IL10RA is a receptor for interleukin 10.…”
Section: Discussionmentioning
confidence: 99%
“…To our best knowledge, most of the studies on FCGR2A have been focused on the inflammation and cerebral vascular diseases. For instance, in a recent study, there was variation in the expression of the FCGR2A gene in the platelets after onset of myocardial infarction [ 24 ]. Besides, FCGR2A single nucleotide polymorphism conferred susceptibility to childhood-onset idiopathic nephrotic syndrome [ 25 ].…”
Section: Discussionmentioning
confidence: 99%
“…In a single center study, we found that high platelet FcγRIIa expression (≥11,000/platelet) is associated with a greater risk (odds ratio > 4) of myocardial infarction (MI), stroke and death (26). Platelet FcγRIIa expression does not require activation of platelets and does not exhibit the magnitude of intra-individual variability seen with platelet function tests (27). The emphasis on platelet activation directly focuses our stroke prevention efforts in ICAD where anti-platelets have been paramount and shear-induced platelet aggregation pivotal.…”
Section: Platelet Reactivity and Platelet Expression Of Fcγriiamentioning
confidence: 99%